125 related articles for article (PubMed ID: 28024722)
41. Oropharyngeal cancer - is it time to change management according to human papilloma virus status?
Mehanna H; Olaleye O; Licitra L
Curr Opin Otolaryngol Head Neck Surg; 2012 Apr; 20(2):120-4. PubMed ID: 22327790
[TBL] [Abstract][Full Text] [Related]
42. Ki67 Expression has Prognostic Significance in Relation to Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma.
Liu J; Zhang M; Rose B; Veillard AS; Jones D; Zhang X; Soon Lee C; Milross C; Hong A
Ann Surg Oncol; 2015; 22(6):1893-900. PubMed ID: 25404475
[TBL] [Abstract][Full Text] [Related]
43. The IL-1/IL-1R axis induces greater fibroblast-derived chemokine release in human papillomavirus-negative compared to positive oropharyngeal cancer.
Al-Sahaf S; Hunter KD; Bolt R; Ottewell PD; Murdoch C
Int J Cancer; 2019 Jan; 144(2):334-344. PubMed ID: 30191960
[TBL] [Abstract][Full Text] [Related]
44. A cross-sectional survey of awareness of human papillomavirus-associated oropharyngeal cancers among general practitioners in the UK.
Lechner M; Vassie C; Kavasogullari C; Jones O; Howard J; Masterson L; Fenton T; Yarbrough W; Waller J; Gilson R
BMJ Open; 2018 Jul; 8(7):e023339. PubMed ID: 30056394
[TBL] [Abstract][Full Text] [Related]
45. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients.
Castellsagué X; Alemany L; Quer M; Halec G; Quirós B; Tous S; Clavero O; Alòs L; Biegner T; Szafarowski T; Alejo M; Holzinger D; Cadena E; Claros E; Hall G; Laco J; Poljak M; Benevolo M; Kasamatsu E; Mehanna H; Ndiaye C; Guimerà N; Lloveras B; León X; Ruiz-Cabezas JC; Alvarado-Cabrero I; Kang CS; Oh JK; Garcia-Rojo M; Iljazovic E; Ajayi OF; Duarte F; Nessa A; Tinoco L; Duran-Padilla MA; Pirog EC; Viarheichyk H; Morales H; Costes V; Félix A; Germar MJ; Mena M; Ruacan A; Jain A; Mehrotra R; Goodman MT; Lombardi LE; Ferrera A; Malami S; Albanesi EI; Dabed P; Molina C; López-Revilla R; Mandys V; González ME; Velasco J; Bravo IG; Quint W; Pawlita M; Muñoz N; de Sanjosé S; Xavier Bosch F;
J Natl Cancer Inst; 2016 Jun; 108(6):djv403. PubMed ID: 26823521
[TBL] [Abstract][Full Text] [Related]
46. Challenges in establishing the diagnosis of human papillomavirus-related oropharyngeal carcinoma.
Truong Lam M; O'Sullivan B; Gullane P; Huang SH
Laryngoscope; 2016 Oct; 126(10):2270-5. PubMed ID: 27074870
[TBL] [Abstract][Full Text] [Related]
47. The Use of HPV16-E5, EGFR, and pEGFR as Prognostic Biomarkers for Oropharyngeal Cancer Patients.
Taberna M; Torres M; Alejo M; Mena M; Tous S; Marquez S; Pavón MA; León X; García J; Guix M; Hijano R; Bonfill T; Aguilà A; Lozano A; Mesía R; Alemany L; Bravo IG
Front Oncol; 2018; 8():589. PubMed ID: 30619735
[No Abstract] [Full Text] [Related]
48. Outcomes after surgical salvage for recurrent oropharyngeal squamous cell carcinoma.
Sweeny L; Rosenthal EL; Clemons L; Stevens TM; Cook McIntosh ER; Carroll WR
Oral Oncol; 2016 Sep; 60():118-24. PubMed ID: 27531882
[TBL] [Abstract][Full Text] [Related]
49. Baseline peripheral blood leukocytosis: Biological marker predicts outcome in oropharyngeal cancer, regardless of HPV-status.
Gouw ZAR; Paul de Boer J; Navran A; van den Brekel MWM; Sonke JJ; Al-Mamgani A
Oral Oncol; 2018 Mar; 78():200-206. PubMed ID: 29496051
[TBL] [Abstract][Full Text] [Related]
50. Ciliated HPV-related Carcinoma: A Well-differentiated Form of Head and Neck Carcinoma That Can Be Mistaken for a Benign Cyst.
Bishop JA; Westra WH
Am J Surg Pathol; 2015 Nov; 39(11):1591-5. PubMed ID: 26457358
[TBL] [Abstract][Full Text] [Related]
51. Concordance of p16
Mena M; Wang X; Tous S; Quiros B; Clavero O; Alejo M; Morey F; Taberna M; Leon Vintro X; Lloveras Rubio B; Alos L; Mehanna H; Quint W; Pawlita M; Tommasino M; Pavón MA; Muñoz N; De Sanjose S; Bosch FX; Alemany L; On Behalf Of The Ico International Hpv In Head And Neck Cancer Study Group
Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954451
[TBL] [Abstract][Full Text] [Related]
52. HPV and other risk factors of oral cavity/oropharyngeal cancer in the Czech Republic.
Tachezy R; Klozar J; Saláková M; Smith E; Turek L; Betka J; Kodet R; Hamsíková E
Oral Dis; 2005 May; 11(3):181-5. PubMed ID: 15888110
[TBL] [Abstract][Full Text] [Related]
53. Predictors of oropharyngeal cancer survival in Europe.
Anantharaman D; Billot A; Waterboer T; Gheit T; Abedi-Ardekani B; Lagiou P; Lagiou A; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Polesel J; Simonato L; Alemany L; Mena Cervigon M; Macfarlane TV; Znaor A; Thomson PJ; Robinson M; Canova C; Conway DI; Wright S; Healy CM; Toner ME; Pawlita M; Tommasino M; Brennan P
Oral Oncol; 2018 Jun; 81():89-94. PubMed ID: 29884419
[TBL] [Abstract][Full Text] [Related]
54. The prevalence of human papilloma virus (HPV) infections in oral squamous cell carcinomas: a retrospective analysis of 88 patients and literature overview.
Krüger M; Pabst AM; Walter C; Sagheb K; Günther C; Blatt S; Weise K; Al-Nawas B; Ziebart T
J Craniomaxillofac Surg; 2014 Oct; 42(7):1506-14. PubMed ID: 24947612
[TBL] [Abstract][Full Text] [Related]
55. From HPV-positive towards HPV-driven oropharyngeal squamous cell carcinomas.
Boscolo-Rizzo P; Pawlita M; Holzinger D
Cancer Treat Rev; 2016 Jan; 42():24-9. PubMed ID: 26547133
[TBL] [Abstract][Full Text] [Related]
56. Patient experience and anxiety during and after treatment for an HPV-related oropharyngeal cancer.
D'Souza G; Zhang Y; Merritt S; Gold D; Robbins HA; Buckman V; Gerber J; Eisele DW; Ha P; Califano J; Fakhry C
Oral Oncol; 2016 Sep; 60():90-5. PubMed ID: 27531878
[TBL] [Abstract][Full Text] [Related]
57. Population-Based Analysis of Trends in Incidence and Survival of Human Papilloma Virus-Related Oropharyngeal Cancer in a Low-Burden Region of Southern Europe.
Rubió-Casadevall J; Ciurana E; Puigdemont M; Sanvisens A; Marruecos J; Miró J; Urban A; Palhua RL; Martín-Romero F; Ortiz-Duran MR; Marcos-Gragera R
Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457669
[No Abstract] [Full Text] [Related]
58. [OROPHARYNGEAL CANCER: THE VIRUS THAT CHANGED THE RULES].
Feibish N; Bartal K; Doweck I
Harefuah; 2020 Feb; 159(1):137-141. PubMed ID: 32048496
[TBL] [Abstract][Full Text] [Related]
59. Role of Human Papillomavirus Infection in Head and Neck Cancer in Italy: The HPV-AHEAD Study.
Tagliabue M; Mena M; Maffini F; Gheit T; Quirós Blasco B; Holzinger D; Tous S; Scelsi D; Riva D; Grosso E; Chu F; Lucas E; Ridder R; Rrehm S; Bogers JP; Lepanto D; Lloveras Rubio B; Vijay Kumar R; Gangane N; Clavero O; Pawlita M; Anantharaman D; Radhakrishna Pillai M; Brennan P; Sankaranarayanan R; Arbyn M; Lombardi F; Taberna M; Gandini S; Chiesa F; Ansarin M; Alemany L; Tommasino M; Chiocca S; The Hpv-Ahead Study Group
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33260360
[TBL] [Abstract][Full Text] [Related]
60. HPV-driven oropharyngeal cancer burden in Paris and its region (ILE DE FRANCE) from 1981 TO 2021.
Mirghani H; Tendron A; Auperin A; Casiraghi O; Classe M; Badoual C; Legoupil C; Puech J; Veyer D; Dalstein V; Pere H; Gorphe P
Cancer Epidemiol; 2024 Jun; 91():102603. PubMed ID: 38901087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
